Beigene, Ltd.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.9Mgeneral payments (2019-2025)
$100Kresearch payments (2019-2025)
848clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| David Schenkein | Boston, MA | Internal Medicine | $814,668.04 |
| Charles Sawyers | New York, NY | Hematology & Oncology | $100,000.00 |
| Arjun Iyengar | New York, NY | Medical Oncology | $92,500.00 |
| Neal Rosen | New York, NY | Medical Oncology | $85,000.00 |
| Ronald Levy | Stanford, CA | Medical Oncology | $85,000.00 |
| Asher Chanan Khan | Jacksonville, FL | Hematology & Oncology | $82,608.50 |
| Elias Jabbour | Houston, TX | Hematology & Oncology | $31,741.00 |
| Jedd Wolchok | New York, NY | Medical Oncology | $28,333.33 |
| Rajwanth Veluswamy | New York, NY | Medical Oncology | $19,430.00 |
| Jae Park | New York, NY | Hematology & Oncology | $18,200.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.